您的位置: 首页 > 农业专利 > 详情页

VACCINE COMPOSITION
专利权人:
OTTAWA HOSPITAL RESEARCH INSTITUTE;CHILDREN'S HOSPITAL OF EASTERN ONTARIO RESEARCH INSTITUTE INC.;MCMASTER UNIVERSITY
发明人:
David F. STOJDL,John Cameron BELL,Brian LICHTY,Jonathan POL
申请号:
US14769035
公开号:
US20160106820A1
申请日:
2014.02.20
申请国别(地区):
US
年份:
2016
代理人:
摘要:
There is described a kit for use in inducing an immune response in a mammal, the kit includes: a first virus that expresses MAGEA3, Human Papilloma Virus E6/E7 fusion protein, human Six-Transmembrane Epithelial Antigen of the Prostate protein, or Cancer Testis Antigen 1, or a variant thereof as an antigenic protein and that is formulated to generate an immunity to the protein or variant thereof in the mammal. The kit also includes a Maraba MG1 virus encoding the same antigen, or a variant of the same antigen. The Maraba MG1 virus is formulated to induce the immune response in the mammal. The first virus is immunologically distinct from the Maraba MG1 virus.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充